Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
Raffaele De Caterina, Stefan Agewall, Felicita Andreotti, Dominick J Angiolillo, Deepak L. Bhatt, Robert A. Byrne, Jean‐Philippe Collet, John W. Eikelboom, Alexander C. Fanaroff, C. Michael Gibson, Andreas Goette, Gerhard Hindricks, Gregory Y.H. Lip, Tatjana Potpara, Hölger Thiele, Renato D. Lópes, Mattía Galli
Abstract
Great Debate: Triple antithrombotic therapy
Topics & Concepts
MedicineAntithromboticPercutaneous coronary interventionConventional PCIAcute coronary syndromeAtrial fibrillationCardiologyInternal medicineCoronary stentingRandomized controlled trialStentMyocardial infarctionRestenosisAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular DiseasesCardiac Arrhythmias and Treatments